Immuneering (IMRX) Change in Cash (2020 - 2026)

Immuneering's Change in Cash history runs 7 years deep, the most recent figure standing at -$81.3 million for Q1 2026.

• In Q1 2026, Change in Cash fell 29045.69% year-over-year to -$81.3 million; the TTM figure through Mar 2026 stood at $11.5 million (up 137.66% YoY), while the FY2025 annual figure was $92.5 million, up 497.66% from the prior year.
• Change in Cash for Q1 2026 stood at -$81.3 million, up from -$98.9 million in the prior quarter.
• The five-year high for Change in Cash was $201.2 million in Q3 2025, with the low at -$98.9 million in Q4 2025.
• The 5-year median for Change in Cash is -$6.6 million (2024), against an average of -$1.6 million.
• The sharpest annual moves came in 2025 and 2026: Change in Cash soared 1485.45% in 2025, then sank 29045.69% in 2026.
• Immuneering's Change in Cash stood at -$3.8 million in 2022, then plunged by 128.37% to -$8.6 million in 2023, then fell by 4.94% to -$9.1 million in 2024, then sank by 991.71% to -$98.9 million in 2025, then advanced by 17.79% to -$81.3 million in 2026.
• Business Quant data shows IMRX's Change in Cash at -$81.3 million in Q1 2026, -$98.9 million in Q4 2025, and $201.2 million in Q3 2025.